🔎 Trials Near Me

Home › Quitting Smoking (Tobacco Use Disorder) › NCT07698470

Brain/Craving Response to Smoking Cues After Oral Nicotine Pouch Use

RecruitingHealthy volunteers welcome

Cue-Exposure Response Evaluation: Brain Reactivity to ONPs

Who can join

Ages 21 to 55 · All sexes · Healthy volunteers welcome

Full eligibility criteria
Inclusion Criteria:

* Age 21 years - 55 years
* Self-reported use of cigarettes within the past 30 days
* Biochemical confirmation of cigarette use:

  o Carbon monoxide (CO) breath sample ≥10 ppm
* Fagerström Test for Nicotine Dependence (FTND) score ≥5, indicating moderate to high nicotine dependence
* Fluent in English
* Willing to try an oral nicotine pouch
* Willing to abstain from nicotine for at least 12 hours prior to each experimental session

Exclusion Criteria:

* Age younger than 21 years or older than 55 years
* Biochemical evidence inconsistent with recent cigarette use:

  o CO breath sample \<10 ppm
* Expressed intent to reduce or quit nicotine use within the next 30 days
* History of medical conditions contraindicated for nicotine use (e.g., uncontrolled hypertension, recent cardiac events)
* Primary use of non-cigarette products (e.g., cigars, pipe tobacco, smokeless tobacco)
* Prior use of oral nicotine products in their lifetime

About the study

Oral nicotine pouches (ONPs) are non-combustible nicotine products that may reduce cigarette craving and smoking cue-induced brain activity, supporting their potential as harm-reduction tools for adults who smoke cigarettes. This within-subject, repeated-measures study will evaluate the acute effects of a single 6 mg oral nicotine pouch on subjective craving and prefrontal neural responses to smoking-related cues using functional near-infrared spectroscopy (fNIRS). Participants will complete assessments before and after nicotine pouch administration following overnight nicotine abstinence to characterize changes in craving and neural cue reactivity.

What is being tested

Sponsor: University of Southern California · Participants: 45 · Started: Apr 30, 2026

Contact the study team

Official record on ClinicalTrials.gov — NCT07698470

Locations in the U.S.

CaliforniaUniversity of Southern California - 3641 Watt Way (HNB B22), Los Angeles

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.